Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole is listed in the pharmaceutical impurity collection under CAS 101954-20-5. Its represented structure has formula C17H26N4O and a calculated molecular weight of 302.42 g/mol.

2D chemical structure

O N N H N N

Chemical identity

Catalog name
1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole
Common name
1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole
Chemical name
2-(1,4-diazepan-1-ylmethyl)-1-(2-ethoxyethyl)benzimidazole
CAS
101954-20-5
SMILES
CCOCCn1c(CN2CCCNCC2)nc2ccccc21
InChI
InChI=1S/C17H26N4O/c1-2-22-13-12-21-16-7-4-3-6-15(16)19-17(21)14-20-10-5-8-18-9-11-20/h3-4,6-7,18H,2,5,8-14H2,1H3
InChIKey
ZLAAITSGMAYYIB-UHFFFAOYSA-N
Associated API
Emedastine Difumarate

Record ID: Aa45c563cb4ed

Computed properties

C17H26N4O Molecular formula
302.422 g/molMolecular weight
302.2107 DaMonoisotopic exact mass
42.32 ŲTopological polar surface area
1.8681 Calculated LogP (Wildman–Crippen)
88.9897 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight302.42245.07
Calculated LogP (Wildman–Crippen)1.868139.99
Topological polar surface area42.3224.19
Hydrogen-bond acceptors450.68
Hydrogen-bond donors138.08
Rotatable bonds (strict)669.73

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC17H26N4Odimensionless
Molecular weight302.422g/mol
Monoisotopic exact mass302.2107Da
Topological polar surface area42.32Ų
Calculated LogP (Wildman–Crippen)1.8681dimensionless
Molar refractivity (Wildman–Crippen)88.9897cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors1count
Rotatable bonds (strict)6count
Heavy atoms22count
Heteroatoms5count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.5882fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area131.8187Ų
Valence electrons120count
Radical electrons0count
Bertz complexity587.3565index
Balaban J1.8092index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole

Qualification and safety assessment of 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole

Explore toxicological qualification of 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole and ICH M7 mutagenic impurity assessment of 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole and acceptable intake and limit justification for 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole

Explore Altox services and software through the Altox Pharma-Hub.